Clinical Trials Directory

Trials / Completed

CompletedNCT03338153

Evaluation of Long-term Coronary Stenting Outcomes in Diabetic Patients With or Without Optimal Glycemic Control

Evaluation of Long-term Coronary Stenting Outcomes in Diabetic Patients With or Without Optimal Glycemic Control Referring to Tehran Heart Center Since June 2007 to June 2009

Status
Completed
Phase
Study type
Observational
Enrollment
1,353 (actual)
Sponsor
Tehran Heart Center · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

the purpose of this study is to determine whether appropriate control of diabetes around the PCI time is related with MACE and outcome of diabetic patients.

Detailed description

Despite recent advances in coronary revascularization, cardiovascular disease accounts for about 75% of all hospital admissions in diabetic patients.although the introduction of drug-eluting stents has reduced the rates of restenosis after PCI, diabetic patients undergoing PCI will have poorer clinical outcomes.In this study, we sought to investigate whether a pre and post procedural glycemic control in diabetic patients,as reflected by HgbA1C prior,1 and 6 months after elective PCI,was related to major advance cardiac events (MACE) during 3 year follow up.

Conditions

Timeline

Start date
2007-10-01
Primary completion
2009-12-01
Completion
2013-03-01
First posted
2017-11-09
Last updated
2017-11-09

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT03338153. Inclusion in this directory is not an endorsement.